» Articles » PMID: 36300187

Recent Advances in the Use of High Flow Nasal Oxygen Therapies

Overview
Specialty General Medicine
Date 2022 Oct 27
PMID 36300187
Authors
Affiliations
Soon will be listed here.
Abstract

High flow nasal oxygen is a relatively new option for treating patients with respiratory failure, which decreases work of breathing, improves tidal volume, and modestly increases positive end expiratory pressure. Despite well-described physiologic benefits, the clinical impact of high flow nasal oxygen is still under investigation. In this article, we review the most recent findings on the clinical efficacy of high flow nasal oxygen in Type I, II, III, and IV respiratory failure within adult and pediatric patients. Additionally, we discuss studies across clinical settings, including emergency departments, intensive care units, outpatient, and procedural settings.

Citing Articles

Effect of Single-Prong Cannula Design With High Velocity Therapy: Comparable Efficacy at Lower Gas Flow Rates.

Atwood C, Sethi J, Bergeski A, Dungan 2nd G, Volakis L, Whittle J Crit Care Explor. 2025; 7(2):e1209.

PMID: 39937568 PMC: 11826042. DOI: 10.1097/CCE.0000000000001209.


A Comprehensive Review on High-Flow Nasal Cannula Oxygen Therapy in Critical Care: Evidence-Based Insights and Future Directions.

Petkar S, Wanjari D, Priya V Cureus. 2024; 16(8):e66264.

PMID: 39238720 PMC: 11375959. DOI: 10.7759/cureus.66264.


Comparison between high-flow nasal cannula and conventional oxygen therapy in COVID-19 patients: a systematic review and meta-analysis.

Wang J, Peng Y, Dai B, Hou H, Zhao H, Wang W Ther Adv Respir Dis. 2024; 18:17534666231225323.

PMID: 38230522 PMC: 10798115. DOI: 10.1177/17534666231225323.

References
1.
Sun J, Li Y, Ling B, Zhu Q, Hu Y, Tan D . High flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease with acute-moderate hypercapnic respiratory failure: an observational cohort study. Int J Chron Obstruct Pulmon Dis. 2019; 14:1229-1237. PMC: 6556470. DOI: 10.2147/COPD.S206567. View

2.
Mauri T, Spinelli E, Pavlovsky B, Grieco D, Ottaviani I, Basile M . Respiratory Drive in Patients with Sepsis and Septic Shock: Modulation by High-flow Nasal Cannula. Anesthesiology. 2021; 135(6):1066-1075. PMC: 10348628. DOI: 10.1097/ALN.0000000000004010. View

3.
Coudroy R, Frat J, Ehrmann S, Pene F, Decavele M, Terzi N . High-flow nasal oxygen alone or alternating with non-invasive ventilation in critically ill immunocompromised patients with acute respiratory failure: a randomised controlled trial. Lancet Respir Med. 2022; 10(7):641-649. DOI: 10.1016/S2213-2600(22)00096-0. View

4.
Leonard S, Atwood Jr C, Walsh B, DeBellis R, Dungan G, Strasser W . Preliminary Findings on Control of Dispersion of Aerosols and Droplets During High-Velocity Nasal Insufflation Therapy Using a Simple Surgical Mask: Implications for the High-Flow Nasal Cannula. Chest. 2020; 158(3):1046-1049. PMC: 7130245. DOI: 10.1016/j.chest.2020.03.043. View

5.
Doshi P, Whittle J, Dungan 2nd G, Volakis L, Bublewicz M, Kearney J . The ventilatory effect of high velocity nasal insufflation compared to non-invasive positive-pressure ventilation in the treatment of hypercapneic respiratory failure: A subgroup analysis. Heart Lung. 2020; 49(5):610-615. DOI: 10.1016/j.hrtlng.2020.03.008. View